Erratum: BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia (Journal of Clinical Immunology DOI: 10.1007/s10875-009-9340-6);BAK, BAX, and NBK/BIK Proapoptotic gene alterations in iranian patients with ataxia telangiectasia

Journal of Clinical Immunology

Volumn 30, Issue 1, 2010, Pages 132-137

  Isaian, Anna ^a,b,c   Bogdanova, Natalia V ^c   Houshmand, Masoud ^a   Movahadi, Masoud ^b   Agamohammadi, Asghar ^b,d   Rezaei, Nima ^b,d   Atarod, Lida ^b   Sadeghi Shabestari, Mahnaz ^e   Tonekaboni, Seyed Hasan ^f   Chavoshzadeh, Zahra ^f   Hassani, Seyed Mohammad Seyed ^a   Mirfakhrai, Reza ^a   Cheraghi, Taher ^b   Kalantari, Najmoddin ^b   Ataei, Mitra ^a   Dork Bousset, Thilo ^c   Sanati, Mohammad Hossein ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TABRIZ   (Iran)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ataxia telangiectasia; BAK; BAX; Cancer; NBK BIK; Polymorphisms

Indexed keywords

NBK BIK PROTEIN; PROTEIN; PROTEIN BAK; PROTEIN BAX; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; IRAN; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 77249107008     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9390-9     Document Type: Erratum

References (27)

1. Yeganeh M, Gambineri E, Abolmaali K, Tamizifar B, Espanol T. Other well-defined immunodeficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo LD, editors. Primary immunodeficiency diseases: definition, diagnosis and management, vol 1. Berlin: Springer; 2008. p. 251-90.
2. N Sandoval M Platzer 1999 Characterization of ATM gene mutations in 66 ataxia telangiectasia families Hum Mol Genet 8 69 79 10.1093/hmg/8.1.69 1:CAS:528:DyaK1MXosleqtw%3D%3D 9887333 (Pubitemid 29039050)
3. Gatti RA. Ataxia-Telangiectasia. http://www.ncbi.nih.gov.book. Gene Reviews 2005.
4. S Perlman S Becker-Catania RA Gatti 2003 Ataxia-telangectasia: diagnosis and treatment Semin Pediatr Neurol 10 173 82 10.1016/S1071-9091(03)00026-3 14653405 (Pubitemid 37414093)
5. M Babaei M Mitui ER Olson RA Gatti 2005 ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype Hum Genet 117 101 6 10.1007/s00439-005-1254-7 1:CAS:528:DC%2BD2MXltlCis7c%3D 15843990 (Pubitemid 43136786)
6. M Martini F D'Alò S Hohaus G Leone LM Larocca 2002 Absence of structural mutations of the Bak gene in B cell lymphomas Haematologica 87 661 2 1:CAS:528:DC%2BD38XlsFCitL4%3D 12031926
7. PF Cartron P Juin L Oliver S Martin K Meflah FM Vallette 2003 Nonredundant role of Bax and Bak in Bid-mediated apoptosis Mol Cell Biol 23 4701 12 10.1128/MCB.23.13.4701-4712.2003 1:CAS:528:DC%2BD3sXltVSitLs%3D 12808108 (Pubitemid 36734757)
8. X Wang 2001 The expanding role of mitochondria in apoptosis Genes Dev 15 2922 33 1:CAS:528:DC%2BD3MXovVOrtbs%3D 11711427
9. S Kondo Y Shinomura Y Miyazaki T Kiyohara S Tsutsui S Kitamura, et al. 2000 Mutation of the Bak gene in human gastric and colorectal cancers Cancer Res 60 4328 30 1:CAS:528:DC%2BD3cXmsVaitbY%3D 10969770
10. SP Kim MS Hwang YR Cho SY Kwon YN Kang IH Kim, et al. 2003 Mutation of Bak gene are infrequent in advanced gastric adenocarcinomas in Koreans Cancer Lett 195 87 91 10.1016/S0304-3835(02)00585-2 1:CAS:528:DC%2BD3sXktFWmsbs%3D 12767516 (Pubitemid 36588983)
11. KM Wani NG Huilgol 2003 Genetic alterations in coding region of the Bak gene in uterine cervical carcinoma Br J Cancer 88 1584 6 10.1038/sj.bjc.6600944 1:CAS:528:DC%2BD3sXktVent7s%3D 12771926 (Pubitemid 36713786)
12. H Peng A Aiello G Packham PG Isaacson L Pan 1998 Infrequent Bax gene mutations in B cell lymphomas J Pathol 186 378 82 10.1002/(SICI)1096- 9896(199812)186:4<378::AID-PATH203>3.0.CO;2-5 1:CAS:528: DyaK1MXmtVyjug%3D%3D 10209486 (Pubitemid 29005456)
13. J Gil H Yamamoto JM Zapata JC Reed M Perucho 1999 Impairment of the pro apoptotic activity of Bax by missense mutations found in gastrointestinal cancers Cancer Res 59 2034 7 1:CAS:528:DyaK1MXjtVWjsrg%3D 10232581
14. V Suleka ML Budarf 2000 Structural analysis of human pro-apoptotic gene BIK Gene 254 157 62 10.1016/S0378-1119(00)00276-6 (Pubitemid 30676165)
15. V Arena M Martini M Luongo A Capelli LM Larocca 2003 Mutations of Bik gene in human peripheral B cell lymphomas Genes Chrom Cancer 38 91 6 10.1002/gcc.10245 1:CAS:528:DC%2BD3sXntVygurs%3D 12874789 (Pubitemid 36994887)
16. M Takagi D Delia 1998 Defective control of apoptosis, radiosensivity, and spindle checkpoint in ataxia telangiectasia Cancer Res 58 4923 9 1:CAS:528:DyaK1cXnt1yisL0%3D 9810001
17. M Moin A Aghamohammadi A Kouhi S Tavassoli N Rezaei SR Ghaffari, et al. 2007 Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients Pediatr Neurol 37 21 8 10.1016/j.pediatrneurol.2007.03.002 17628218 (Pubitemid 47030790)
18. JC Reed 2008 Bcl-2 family proteins and hematologic malignancies: history and future prospects Blood 111 3322 30 10.1182/blood-2007-09-078162 1:CAS:528:DC%2BD1cXktlWnu7k%3D 18362212
19. http://www.ncbi.nlm.nih.gov/SNP/index.html.
20. PF Cartron P Juin L Oliver K Meflah FM Vallette 2003 Impact of proapoptotic proteins Bax and Bak in tumor progression and rerponse to treatment Expert Rev Anticancer Ther 3 563 70 10.1586/14737140.3.4.563 1:CAS:528:DC%2BD3sXnt1ylsLY%3D 12934667
21. JP Meijerink EJ Mensink K Wang TW Sedlak AW Slöetjes T de Witte, et al. 1998 Hematopoietic malignancies demonstrate loss-of-function mutations of BAX Blood 91 2991 7 1:CAS:528:DyaK1cXisVWlurc%3D 9531611
22. N Rampino H Yamamoto Y Ionov Y Li H Sawai JC Reed, et al. 1997 Somatic frameshift mutations in the Bax gene in colon cancers of the microsatellite mutator phenotype Science 275 967 9 10.1126/science.275.5302.967 1:CAS:528:DyaK2sXht1Cksrk%3D 9020077 (Pubitemid 27087710)
23. A Castells Y Ino DN Louis V Ramesh JF Gusella AK Rustgi 1999 Mapping of a target region of allelic loss to a 0.5 cM interval on chromosome 22q13 in human colorectal cancer Gastroenterology 117 831 7 10.1016/S0016-5085(99)70341-0 1:CAS:528:DyaK1MXmvVWnu7o%3D 10500065 (Pubitemid 29468225)
24. N García F Salamanca H Astudillo-de la Vega E Curiel-Quesada I Alvarado R Peñaloza, et al. 2005 A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females BMC Cancer 5 93 10.1186/1471-2407-5-93 16060964 (Pubitemid 41461042)
25. J Eberle AM Hossini 2008 Expression and function of bcl-2 proteins in melanoma Curr Genomics 9 409 19 10.2174/138920208785699571 1:CAS:528: DC%2BD1cXhtVSrs73I 19506730
26. J Eberle LF Fecker AM Hossini BM Kurbanov H Fechner 2008 Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma Exp Dermatol 17 1 11 1:CAS:528:DC%2BD1cXisVynsr8%3D 18095940
27. M Fernet S Angele T Dörk J Hall 2003 Variation in radiation-induced apoptosis in ataxia-telangiectasia lymphoblastoid cell lines Int J Radiat Biol 79 193 202 10.1080/0955300031000085731 1:CAS:528:DC%2BD3sXivFOgsLc%3D 12745884 (Pubitemid 36535178)